Evaxion Biotech A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$1.10 | -$1.10 | -$1.10 |
| Q2 2024 | 0 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2024 | 2 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2024 | 0 | -$0.29 | -$0.29 | -$0.29 |
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2026 | 0 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2026 | 0 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2026 | 0 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2026 | 0 | -$0.14 | -$0.14 | -$0.14 |
Evaxion Biotech A/S Earnings Date And Information
Evaxion Biotech A/S last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07091 by $0.04909. The company had revenue of 153,887 for the quarter and had revenue of 73,112 for the year. Evaxion Biotech A/S has generated $-8 earnings per share over the last year ($-8.11 diluted earnings per share) and currently has a price-to-earnings ratio of -1.15. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Evaxion Biotech A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/28/2024 | Q2 2024 | -$1.14 | $52,000 | $153,887 | ||
| 08/14/2024 | Q1 2024 | -$0.07 | $0.26 | 0.33 | $50,881 | |
| 03/26/2024 | Q4 2023 | -$1.67 | $73,597 | $73,597 | ||
| 09/07/2023 | Q3 2023 | -$2.05 | $0 | |||
| 08/17/2023 | Q2 2023 | -$2.10 | $0 | |||
| 08/17/2023 | Q1 2023 | -$2.42 | $0 | |||
| 04/27/2023 | Q4 2022 | -$2.85 | $0 | |||
| 04/27/2023 | Q3 2022 | -$2.41 | $0 | |||
| 06/30/2022 | Q2 2022 | -$2.05 | $0 | |||
| 03/31/2022 | Q1 2022 | -$2.50 | $0 | |||
| 03/31/2022 | Q4 2021 | -$3.86 | $0 | |||
| 09/30/2021 | Q3 2021 | -$2.73 | $0 | |||
| 06/30/2021 | Q2 2021 | -$3.60 | $0 | |||
| 03/31/2021 | Q1 2021 | -$2.30 | $0 | |||
| 04/07/2021 | Q4 2020 | -$2.63 | $0 | |||
| 09/30/2020 | Q3 2020 | -$2.48 | $0 | |||
| 06/30/2020 | Q2 2020 | -$1.90 | $0 | |||
| 03/31/2020 | Q1 2020 | -$1.61 | $0 | |||
| 12/31/2019 | Q4 2019 | -$1.83 | $0 |
Evaxion Biotech A/S Earnings: Frequently Asked Questions
-
When is Evaxion Biotech A/S's earnings date?
Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Evaxion Biotech A/S's earnings conference call?
The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online.
-
How can I read Evaxion Biotech A/S's conference call transcript?
The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online.
-
How much revenue does Evaxion Biotech A/S generate each year?
Evaxion Biotech A/S (:EVAX) has a recorded annual revenue of $73,112.
-
How much profit does Evaxion Biotech A/S generate each year?
Evaxion Biotech A/S (:EVAX) has a recorded net income of $73,112. Evaxion Biotech A/S has generated $-8.11 earnings per share over the last four quarters.
-
What is Evaxion Biotech A/S's price-to-earnings ratio?
Evaxion Biotech A/S (:EVAX) has a price-to-earnings ratio of -1.15 and price/earnings-to-growth ratio is -0.07.
